|
Oct 8
|
NeoGenomics (NEO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
|
|
Oct 8
|
NeoGenomics Launches AML Express for Rapid Genetic Profiling of Acute Myeloid Leukemia
|
|
Sep 11
|
NeoGenomics to Present New Data at ESMO 2024, Highlighting the Value of ctDNA and NGS for Advancing Cancer Diagnostics and Personalized Treatment
|
|
Jul 29
|
NeoGenomics: Q2 Earnings Snapshot
|
|
Jul 29
|
NeoGenomics Reports Second Quarter 2024 Results
|
|
Jun 13
|
Fort Myers’ Mayor to Proclaim June as NeoGenomics’ Commitment to Cancer Month
|
|
May 2
|
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript
|
|
May 2
|
NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 1
|
NeoGenomics Inc (NEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
|
|
Apr 30
|
Here's What Key Metrics Tell Us About NeoGenomics (NEO) Q1 Earnings
|
|
Apr 30
|
NeoGenomics Q1 2024 Earnings: Revenue Surpasses Estimates, Net Loss Narrows
|
|
Apr 30
|
NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates
|
|
Apr 30
|
NeoGenomics Reports First Quarter 2024 Results
|
|
Apr 24
|
Will Myriad Genetics (MYGN) Report Negative Q1 Earnings? What You Should Know
|
|
Apr 23
|
NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Apr 18
|
NeoGenomics Announces Senior Leadership Promotions
|
|
Apr 10
|
Absci Corporation (ABSI) Moves 16.8% Higher: Will This Strength Last?
|
|
Apr 9
|
NeoGenomics to Report First Quarter 2024 Financial Results on April 30, 2024
|
|
Mar 27
|
NeoGenomics Showcases Commitment to Transforming Cancer Patient Care at AACR 2024 Annual Meeting
|
|
Mar 20
|
All You Need to Know About NeoGenomics (NEO) Rating Upgrade to Buy
|